新型诺罗病毒GII.4变种的出现
Emerging infectious diseases
|December 8, 2023
概括
发现了一种新的诺罗病毒GII.4变种,其外表蛋白质发生了关键变化. 早期检测这种诺罗病毒变种对于疫情准备和疫苗策略至关重要.
科学领域:
- 病毒学 病毒学
- 分子流行病学分子流行病学
- 公共卫生 公共卫生
背景情况:
- 诺罗病毒GII.4菌株是全球流行性胃肠炎的最常见原因.
- 需要持续监测以检测具有改变抗原或流行病学特性的新兴变异.
研究的目的:
- 报告检测到一种新型诺罗病毒GII.4变种.
- 描述与这种新型变异相关的遗传变化.
主要方法:
- 在临床样本中检测诺罗病毒RNA.
- 病毒蛋白1 (VP1) 基因的序列分析.
- 遗传学分析以识别新型变异.
主要成果:
- 发现了一种新的GII.4诺罗病毒变种.
- 这种变体在VP1.1中的表位A开始具有氨基酸插入.
- 该变种在2017年至2022年期间在美国,加,南非和英国的样本中被检测到.
结论:
- 这种新型GII.4变种的出现凸显了诺罗病毒正在进行的演变.
- 早期识别和描述GII.4变种对于监测流行病潜力至关重要.
- 这些发现可以为诺罗病毒疫苗开发和公共卫生战略提供信息.
相关概念视频
Transmission-based Precautions I: Contact, Enteric, and Droplets
3.6K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
3.6K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
164
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
164
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
124
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
124
Drugs for Treatment of Diarrhea-Predominant IBS
179
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
179
Healthcare Associated Infections II: Preventive Measures
2.6K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.6K
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
4.2K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.2K


